United States - Israel Binational Science Foundation Report issue

Foundation

Organization Overview

First Clinical Trial
1998
NCT00162461
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

phenytoin (mesantoin) (1 trial)

warfarin (coumadin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2